Gritstone Bio Inc (GRTS) - News Archive

Breaking Ground: Promising Phase 2 Data for Gritstone bio s GRANITE Immunotherapy in Colorectal CancerIn a significant stride towards advancing cancer immunotherapy, Gritstone bio has announced promising interim data fr...

In an exclusive report by CSIMarket.com , we delve into the recent developments surrounding Gritstone Bio, Inc. and its ongoing securities class action lawsuit. Trusted and leading law firm, Rosen, highlights the signif...

In a recent announcement, Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company committed to revolutionizing vaccine development, revealed the grant of nonqualified stock options to a new employee....

The ongoing battle against the COVID-19 pandemic has emphasized the crucial role of effective vaccines in controlling the spread of the virus. With new variants emerging, it is imperative to develop vaccines that provid...

Revolutionizing Cancer Vaccines: Gritstone Bio s Breakthrough SLATE Platform Unveils Potent KRAS-Specific CandidateNature Medicine has recently published the interim results of Gritstone Bio s Phase 1/2 study, shedding...

Gritstone Bio, Inc. Announces Public Offering of Common Stock and WarrantsGritstone Bio, Inc., a leading biotechnology company focused on developing innovative vaccines, recently announced its commencement of an underwr...

Gritstone bio has announced positive preliminary results from the Phase 2 portion of its ongoing Phase 2/3 study of the cancer vaccine, GRANITE. The study concentrates on front-line metastatic Microsatellite Stable Colo...

EMERYVILLE, Calif., Feb. 12, 2024 - Gritstone bio, Inc. (Nasdaq: GRTS), a pioneering biotechnology company focused on developing the world s most powerful vaccines, has shared an important update on its comparative Phas...

Pharmaceutical Company Gritstone Bio Grants Stock Options to New Employees, Impacting ShareholdersEmeryville, California - Gritstone Bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company renowned for developi...